Wall Street Analysts Predict a 131.33% Upside in Oric Pharmaceuticals (ORIC): Here's What You Should Know

Core Viewpoint - Oric Pharmaceuticals, Inc. (ORIC) has seen a significant stock price increase of 44.1% over the past four weeks, closing at $8.17, with analysts suggesting a potential upside to a mean price target of $18.90, indicating a 131.3% increase from the current price [1] Price Targets and Analyst Consensus - The average price target from analysts ranges from a low of $12 to a high of $25, with a standard deviation of $4.04, suggesting a potential increase of 46.9% to 206% from the current price level [2] - A low standard deviation indicates a strong agreement among analysts regarding the price targets, which can be a useful indicator for further research [2][9] Earnings Estimates and Market Sentiment - Analysts have shown strong agreement in revising earnings per share (EPS) estimates higher, which correlates with potential stock price increases [4][11] - Over the last 30 days, five estimates for ORIC have increased, leading to a 12.6% rise in the Zacks Consensus Estimate for the current year [12] Zacks Rank and Investment Potential - ORIC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13]